Combination Therapy with Coagulation Factors and Multispecific Antibodies
- 专利权人:
- Hoffmann-La Roche Inc.
- 发明人:
- Andreas Calatzis,Katharina Lechner
- 申请号：
- US15784478
- 公开号：
- US20180244798A1
- 申请日:
- 2017.10.16
- 申请国别(地区):
- US
- 年份:
- 2018
- 代理人:
- 摘要：
- The invention relates to therapies for a patient with bleeding disorders, comprising the application of certain blood coagulation (clotting) factors in combination with antibodies.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Combination therapy with coagulation factors and multispecific antibodies
- Combination therapy for cancer using anti-GITR antibody
- Combination therapy with an inhibitor of human proliferation and differentiation factor 15 (GDF-15) and an immune checkpoint blocker
- On the basis of the following factors,
- Anti-CD47 combination therapy
